Fusion protein based on CjCas9 and VPR core structure domains, corresponding DNA targeting activation system and application of system
Patent Information
- Authority / Receiving Office
- CN ยท China
- Current Assignee / Owner
- SOUTHERN MEDICAL UNIVERSITY
- Publication Date
- 2019-10-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, and relates to a fusion protein based on CjCas9 and its mutants and a VPR core domain, a corresponding DNA targeting activation system and applications thereof. Background technique
[0002] The CRISPR / Cas9 system is currently a widely used gene editing system, which is transformed from the adaptive immune mechanism of bacteria and archaea to degrade foreign DNA. The CRISPR / Cas9 system mainly consists of two components: Cas9 protein and guide RNA. After the combination of Cas9 protein and guide RNA, it will cut the double strand of DNA at a specific site under the guidance of guide RNA, resulting in a break, which is much simpler than the previous gene editing method. In recent years, the CRISPR / Cas9 system has also been gradually applied in the field of gene regulation. Using the CRISPR / Cas9 system that has lost its cleavage activity and combined with transcriptional activators or repressors can a...